KalVista Pharmaceuticals (KALV) FDA Announcement Transcript

KalVista Pharmaceuticals (KALV) FDA Announcement July 07, 2025 08:30 AM ET Speaker0 Good day and thank you for standing by. Welcome to the Calvista Pharmaceuticals FDA Approval Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. Speaker1 I would now like to hand Speaker0 the conference over to Ryan Baker, Head of Investor Relations. Please go ahead. Speaker2 ...